Foresite Capital Management IV

Latest statistics and disclosures from Foresite Capital Management IV's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are PHVS, KURA, LYEL, RLAY, and represent 100.00% of Foresite Capital Management IV's stock portfolio.
  • Reduced shares in these 2 stocks: SNDX (-$17M), KURA.
  • Sold out of its position in SNDX.
  • Foresite Capital Management IV was a net seller of stock by $-18M.
  • Foresite Capital Management IV has $109M in assets under management (AUM), dropping by -28.90%.
  • Central Index Key (CIK): 0001704132

Tip: Access up to 7 years of quarterly data

Positions held by Foresite Capital Management IV consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Foresite Capital Management IV

Foresite Capital Management IV holds 4 positions in its portfolio as reported in the December 2024 quarterly 13F filing

Company (Ticker)
Portfolio Weight
Valued At
Change in Shares
Share Count
Share Price
Pharvaris N V (PHVS) 77.5 $84M 4.4M 19.17
 View chart
Kura Oncology (KURA) 13.8 $15M -6% 1.7M 8.71
 View chart
Lyell Immunopharma (LYEL) 4.9 $5.3M 8.3M 0.64
 View chart
Relay Therapeutics (RLAY) 3.8 $4.1M 1.0M 4.12
 View chart

Past Filings by Foresite Capital Management IV

SEC 13F filings are viewable for Foresite Capital Management IV going back to 2017

View all past filings